https://ryortho.com/ (press release) (subscription)Stem cells: the future of medicineMedical XpressWhile human embryos contain embryonic stem cells, which help them to develop, the use of those cells has been controversial. The scientists are using ind… Continue reading
Takeda prepping to take over EU production of stem cell therapy from 2021BioPharma-Reporter.comFollowing its acceptance for review by the European Medicines Agency (EMA), Takeda and TiGenix announced this week Swissmedic has accepted for review the fil… Continue reading
STAT |
Bluebird Bio’s gene therapy for blood disorders yields some impressive results ― but also raises questions
STAT he field of gene therapy is making significant strides towards the day when a one-time treatment ― inserting a healthy gene into patients ― could cure a host of inherited, often fatal diseases. But it’s been a rocky road 1. And new clinical data … Drug Product in Patients with Transfusion-Dependent β-Thalassemia (TDT) and Severe Sickle Cell Disease (SCD) at …Business Wire (press release) bluebird bio (BLUE) Announces Early Data from Phase 3 Northstar-2 (HGB-207) Study of LentiGlobinTM Drug Product …StreetInsider.com |
Xconomy |
Bluebird Reports Early Results From Upgraded Gene Therapy
Xconomy One of the year’s most closely watched clinical studies could lead to a landmark approval of a gene therapy and throw wide open the debate over how to pay for expensive drugs. The first drips of data have emerged. Bluebird Bio (NASDAQ: BLUE) says the … Bluebird Bio’s gene therapy for blood disorders yields some …STAT Early Data for bluebird bio Gene–Therapy Candidate Show Some PromiseGenetic Engineering & Biotechnology News Bluebird Bio rebuilds case for blood disorder gene therapyFierceBiotech Endpoints News –Business Wire (press release) all 10 news articles » |
Medgadget (blog) |
Global Stem Cell Cartilage Regeneration Market 2017: Genzyme, CellGenix, EMD Serono and Sanofi Aventis
Medgadget (blog) A market study based on the ” Stem Cell Cartilage Regeneration ” across the globe, recently added to the repository of Market Research, is titled ‘Global Stem Cell Cartilage Regeneration Market 2017′. The Research report by QY Research Group is a … |